Ikaria, Inc.


BiotechProfiles™ is the premier resource for jobs, company information, professional networking and productivity tools in the Madison, Wisconsin biotechnology and medical device industry. Recognized as one of the premier emerging biotechnology clusters in the U.S., this robust industry sector comprises nearly 10,000 employees in approximately 150 companies. BiotechProfiles also maintains a unique directory of the largest 250 pharmaceutical companies worldwide, including business development contacts whenever available. This tool is indispensable for executives pursuing strategic alliances and technology licenses.
Designed as a suite of easy to use, searchable databases that are continually updated, BiotechProfiles serves the needs of biotech business development and operational executives in early stage companies, as well as the general public. With these tools you can quickly bypass the data collection and screening stage and immediately focus on solving your strategic partnering or operational needs. We've assembled your background data for you!
  Next »

BiotechProfiles is also the premier site for data on Biotechnology Companies in Madison Wisconsin, Biotechnology Jobs in Madison Wisconsin

Biotechnology Companies in Madison Wisconsin; Biotechnology Jobs in Madison Wisconsin
  « Previous | Next »

Biotechnology Business Development, Partnering and Strategic Alliances

Biotechnology Business Development, Partnering and Strategic Alliances
  « Previous | Next »

Madison Biotechnology Companies; Madison Biotechnology Jobs

Madison Biotechnology Companies; Madison Biotechnology Jobs
  « Previous | Next »

List or rank of Largest Pharmaceutical Companies Worldwide

List of rank of Largest Pharmaceutical Companies Worldwide
  « Previous


Company Profile

Ikaria Holdings, a unit of Mallinckrodt Pharmaceuticals, is a fully integrated critical care therapeutics company based in Seattle WA. Ikaria is positioned as a leader in products based on hydrogen sulfide, nitric oxide, carbon monoxide, and other novel drug candidates. An Ikaria core competency is the development and commercialization of drug delivery devices and drug/device combinations that support clinical applications. The company's Madison site is the device headquarters, focused on manufacturing specialized delivery devices.

(Note: Ikaria has no dedicated website for its Madison operations.)
Business Sectors
Pharmaceuticals   Human Diagnostics  
Med or Lab Devices Lab Reagents or Services  
Drug Manufacturing   Food & Agribusiness  
CRO   Bioinformatics or Software  
Company History
INO Therapeutics' R&D group in Madison evolved from an alliance formed in Dec 1999 between INO Therapeutics Inc of Clinton NJ and Madison based Datex-Ohmeda. Datex-Ohmeda had developed its INOvent delivery system, an integrated unit that both administered and monitored nitric oxide inhalation therapy, which could deliver INO's INOmax nitric oxide. In 2007, Ikaria Holdings acquired INO Therapeutics. In 2015, Mallinckrodt Pharmaceuticals acquired Ikaria.
Ikaria, Inc.
Address 2902 Dairy Drive
[Map] Madison
Phone 608-226-3400
Fax 608-395-3905
Head Dave Shank
Company Statistics
Global Headcount 28
Local Headcount 28
Year Founded 1999
Ownership Subsidiary
Stock Exchange

Parent Company
Divisional Level Ikaria, Inc.
Senior Level Mallinckrodt [St.Louis, Mo]
Global Headcount
Website Link
Stock Exchange NYSE
Reference Documents
Corporate Profile
Ikaria Corporate Brochure May 2008 [View]
2010 - Ikaria Inc SEC Form S-1 May 2010 [View]
Selected Press Releases
2008 - Kennedy Named SVP Engineering & Operations [View]